Stress pathways and heart failure (Q33734297)

29 July 2017

1 reference

title

Stress pathways and heart failure (English)

1 reference

29 July 2017

0 references

Chien KR

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

98

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

555-558

1 reference

MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Complexity in simplicity: monogenic disorders and complex cardiomyopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Dystroglycan versatility

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Genetically engineered mice: model systems for left ventricular failure

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

neu tack on neuregulin

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Severe cardiomyopathy in mice lacking dystrophin and MyoD

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

Signal-regulated activation of serum response factor is mediated by changes in actin dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980043-4

7 January 2021

10.1016/S0092-8674(00)80043-4

Identifiers

DOI

1 reference

29 July 2017

1 reference